Cervix BT - 2016

DOSIMETRIC COMPARISON: Retrospective Vs Prospective Data Vs Literature

Vienna (IC) VIE (IC/IS) Brabandere

TMH: RD

TMH: PD

HRCTV Vol in cc

46.9+24.6

45.2 + 15.8 54.1 + 6.5 70.9 + 10.6 73.4 + 4.5 80.4 + 34.4 139.1 + 54.7 93.4 + 24.6

34 +/- 17 66 +/- 7 87 +/-10 82 +/- 9

44 +/- 27 70 +/- 6 96 +/- 12

48+/-19 64+/-6 79+/-7 79+/-5

65.7+4.6

D100

88.3+4.4 93.1 +24.8

D90

Avg. Pt A

--

Bladder ICRU Bladder

75 +/-16 121+/-25 LESSONS LEARNT Prospective Data: 94 patients HR-CTV Volumes larger: Advanced Stages Higher doses to HR-CTV Bladder and Sigmoid Doses Better 73 +/- 19 113+/- 30 83 +/-14 74+/-15 100+/-12 D0.1cc D2cc 83 +/-9 82+/-6 Rectum ICRU Rectum 69 +/- 13 77 +/- 10 71 +/- 13 77 +/- 9 66 +/- 6 66+/-9 68+/-7 62+/-4 D0.1cc D2cc 64+/- 6

76.4 +15.5 109.6 +19.7 85.7+9.8

63.5 + 8.1 66 + 9.9 57.8 + 7.7

68 +7.9

71.5 +7.5 65.5+7.2

Sigmoid D0.1cc

109.4 + 45.2 74.6 + 19.6

74 +8.6 67+8.8

79 +/- 12 63 +/- 7

85 +/- 14 67 +/- 7

82+/-13 68+/-7

D2cc